Nutrien (NYSE:NTR) had its price target raised by Macquarie from $59.00 to $66.00 in a research report released on Friday. They currently have an outperform rating on the stock.
NTR has been the topic of several other research reports. Raymond James boosted their price target on Nutrien from $65.00 to $67.00 and gave the stock a strong-buy rating in a research note on Friday, August 3rd. Stephens set a $64.00 price target on Nutrien and gave the stock a buy rating in a research note on Monday, August 6th. Zacks Investment Research lowered Nutrien from a buy rating to a hold rating in a research note on Wednesday, August 1st. Royal Bank of Canada set a $63.00 price target on Nutrien and gave the stock a buy rating in a research note on Thursday, August 2nd. Finally, Scotiabank lowered Nutrien from a focus list rating to an outperform rating in a research note on Thursday, September 20th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company’s stock. Nutrien presently has a consensus rating of Buy and an average price target of $62.12.
Shares of NYSE:NTR traded up $0.01 during trading on Friday, hitting $54.07. 1,680,630 shares of the stock were exchanged, compared to its average volume of 1,709,565. Nutrien has a 12-month low of $40.41 and a 12-month high of $58.99.
Nutrien (NYSE:NTR) last announced its quarterly earnings results on Wednesday, August 1st. The company reported $1.48 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.40 by $0.08. The business had revenue of $8.15 billion for the quarter, compared to analyst estimates of $7.70 billion. Nutrien had a return on equity of 10.27% and a net margin of 9.83%. The company’s revenue for the quarter was up 10.8% compared to the same quarter last year. Analysts expect that Nutrien will post 2.55 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 19th. Investors of record on Friday, September 28th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.96%. The ex-dividend date of this dividend is Thursday, September 27th.
Hedge funds have recently bought and sold shares of the stock. Great West Life Assurance Co. Can lifted its stake in Nutrien by 1.9% in the 2nd quarter. Great West Life Assurance Co. Can now owns 5,110,815 shares of the company’s stock valued at $278,927,000 after buying an additional 95,380 shares in the last quarter. Bank of Nova Scotia lifted its stake in Nutrien by 4.9% in the 2nd quarter. Bank of Nova Scotia now owns 2,536,579 shares of the company’s stock valued at $137,340,000 after buying an additional 118,546 shares in the last quarter. Oppenheimer & Co. Inc. lifted its stake in Nutrien by 8.5% in the 2nd quarter. Oppenheimer & Co. Inc. now owns 39,340 shares of the company’s stock valued at $2,140,000 after buying an additional 3,088 shares in the last quarter. Morgan Stanley raised its holdings in Nutrien by 2.9% in the 2nd quarter. Morgan Stanley now owns 1,599,898 shares of the company’s stock valued at $87,002,000 after acquiring an additional 45,417 shares during the last quarter. Finally, US Bancorp DE raised its holdings in Nutrien by 17.1% in the 2nd quarter. US Bancorp DE now owns 43,311 shares of the company’s stock valued at $2,354,000 after acquiring an additional 6,327 shares during the last quarter. 66.34% of the stock is currently owned by hedge funds and other institutional investors.
Nutrien Ltd. produces and markets crop nutrients worldwide. The company offers potash, nitrogen, phosphate, and solid and liquid phosphate fertilizers; and phosphate feed, ammonium sulfate, and industrial acid products. It also retails seeds, crop protection and crop nutrient products, merchandise products, and agronomic services through operating 1,500 retail locations.
Recommended Story: What is the balance sheet?
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.